ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Apples to Apples: Playing the Comparability Game in Biotherapeutics Development"
Episode Synopsis
Comparability studies are a significant issue for those working in biotherapeutics development, as undetected product changes are considered high risk. Listen as Kevin Hennegan, Lisa Erickson and Sarah Roemer take us through several considerations when Playing the Comparability Game in Biotherapeutics Development.
More episodes of the podcast Advancing Revolutionary Therapies
CMC Pitfalls: From Benchtop to IND
31/10/2022
Emergency Use Authorizations
22/09/2022
Orphan Drug Designations and Orphan Subsets
11/09/2022
Season 3 Trailer
26/08/2022
In God we trust